The main purpose of this legislation, known as the "Stop Superbugs Act," is to combat antibiotic resistance by establishing a clinical research network. This network aims to enhance the understanding and treatment of infections caused by antibiotic-resistant bacteria, which pose a significant threat to public health. Key provisions of the legislation require the Director of the National Institute of Allergy and Infectious Diseases to provide a competitive grant to the Antibiotic Resistance Leadership Group. This grant will support several important activities.